{"id":"https://openalex.org/W3082967940","doi":"https://doi.org/10.1158/1538-7445.am2020-4124","title":"Abstract 4124: The combination of PARP inhibitor talazoparib with low-dose temozolomide results in increased cell lethality in BRCA1/2 wild-type melanoma, small cell lung cancer, ovarian, and colon cancer cell lines and mouse xenografts via the formation of DNA double-strand breaks during S-phase","display_name":"Abstract 4124: The combination of PARP inhibitor talazoparib with low-dose temozolomide results in increased cell lethality in BRCA1/2 wild-type melanoma, small cell lung cancer, ovarian, and colon cancer cell lines and mouse xenografts via the formation of DNA double-strand breaks during S-phase","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3082967940","doi":"https://doi.org/10.1158/1538-7445.am2020-4124","mag":"3082967940"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-4124","doi":"https://doi.org/10.1158/1538-7445.am2020-4124","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-4124","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062438676","display_name":"Kelly Elizabeth McCann","orcid":"https://orcid.org/0000-0001-8233-6242","observed_orcids":["https://orcid.org/0000-0001-8233-6242"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly Elizabeth McCann","raw_affiliation_strings":["UCLA, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Santa Monica, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045874340","display_name":"Erika von Euw","orcid":"https://orcid.org/0000-0002-3201-3311","observed_orcids":["https://orcid.org/0000-0002-3201-3311"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erika von Euw","raw_affiliation_strings":["UCLA, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Santa Monica, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028010756","display_name":"Neil A. O\u2019Brien","orcid":"https://orcid.org/0000-0001-7408-1091","observed_orcids":["https://orcid.org/0000-0001-7408-1091"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neil O'Brien","raw_affiliation_strings":["UCLA, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Santa Monica, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015491002","display_name":"Dennis J. Slamon","orcid":"https://orcid.org/0000-0002-6330-498X","observed_orcids":["https://orcid.org/0000-0002-6330-498X"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis Slamon","raw_affiliation_strings":["UCLA, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Santa Monica, CA","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"4124","last_page":"4124"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/talazoparib","display_name":"talazoparib","score":0.9760000109672546},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.9909999966621399},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.9039999842643738},{"id":"https://openalex.org/keywords/dna-double-strand-breaks","display_name":"DNA double-strand breaks","score":0.843999981880188},{"id":"https://openalex.org/keywords/homologous-recombination-repair","display_name":"homologous recombination repair","score":0.7110000252723694},{"id":"https://openalex.org/keywords/parp-trapping","display_name":"PARP trapping","score":0.4880000054836273},{"id":"https://openalex.org/keywords/h2ax-phosphorylation","display_name":"H2AX phosphorylation","score":0.8949999809265137},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6190000176429749},{"id":"https://openalex.org/keywords/cell-cycle-checkpoints","display_name":"cell cycle checkpoints","score":0.5120000243186951},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5830000042915344},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9309999942779541},{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.8889999985694885},{"id":"https://openalex.org/keywords/mouse-xenograft-model","display_name":"xenograft mouse model","score":0.8140000104904175}],"concepts":[{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.7485550045967102},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7232961058616638},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.6964958310127258},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5833280682563782},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5460708737373352},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.5367563366889954},{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.5172737240791321},{"id":"https://openalex.org/C2778502085","wikidata":"https://www.wikidata.org/wiki/Q7662767","display_name":"Synthetic lethality","level":4,"score":0.49831175804138184},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46106892824172974},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.3038191497325897},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28924840688705444},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24533706903457642},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.1202944815158844},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08311507105827332},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.0704072117805481},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-4124","doi":"https://doi.org/10.1158/1538-7445.am2020-4124","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-4124","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7220659366","https://openalex.org/W2594265850","https://openalex.org/W2604665854","https://openalex.org/W2601536553","https://openalex.org/W2399357550","https://openalex.org/W4313368192","https://openalex.org/W2033207806","https://openalex.org/W2336997490","https://openalex.org/W2787300557","https://openalex.org/W4389227568"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Previous":[2],"studies":[3],"of":[4,40,52,61,84,89,175,191,245,282,293,301,321,350,388,401,434,438,454,463,487,519,528,532],"PARP":[5,41,66,75,91,113,182,211,351,427,455,488],"inhibitors":[6,42,212,428],"have":[7,71,213,430],"shown":[8,73,215],"efficacy":[9,106,400,423],"in":[10,14,19,36,86,116,122,148,168,298,309,313,359,378,406,461,495,499],"tumors":[11,283],"with":[12,21,26,46,55,58,64,112,118,144,261,272,295,424,491],"defects":[13],"homologous":[15],"recombination":[16],"repair,":[17],"particularly":[18,444],"persons":[20],"ovarian":[22],"and":[23,105,154,159,177,194,208,228,256,287,318,325,352,411,414,422,452,508,513,543],"breast":[24],"cancers":[25],"germline":[27],"deleterious":[28],"BRCA1/2":[29,314,407,500],"mutations":[30],"(gBRCA1/2+).":[31],"There":[32],"is":[33,76,383,448],"much":[34],"interest":[35],"expanding":[37],"the":[38,50,79,82,87,137,181,218,299,360,396,415,439,457,517,529,533],"use":[39],"beyond":[43,432],"these":[44],"populations,":[45],"one":[47],"strategy":[48],"being":[49],"creation":[51],"DNA":[53,80,229,246,302,458,470,520],"damage":[54,85],"cytotoxic":[56],"chemotherapy":[57],"concomitant":[59],"inhibition":[60,190],"its":[62],"repair":[63,230],"a":[65,90,131,243,464,469],"inhibitor.":[67,92],"Murai,":[68],"et":[69],"al,":[70],"also":[72,366],"that":[74],"trapped":[77],"on":[78,456],"at":[81,108,197,205,375],"site":[83],"presence":[88],"In":[93],"April":[94],"2016,":[95],"my":[96],"colleague":[97],"Dr":[98],"Zev":[99],"Wainberg":[100],"presented":[101],"Phase":[102,416],"I":[103,417],"safety":[104,421],"data":[107,398,419],"AACR":[109],"(abstract":[110],"CT011)":[111],"inhibitor":[114,183,489],"talazoparib":[115,145,167,296,340,402,490],"combination":[117,195,288,292,486],"alkylating":[119,440],"agent":[120,441],"temozolomide":[121,147,294,342,404,493],"cancer":[123,141,156,510],"patients":[124],"without":[125],"gBRCA1/2+,":[126],"demonstrating":[127,399],"this":[128,382,425],"to":[129,171,180,216,237,252,257,269,279,284,338,347,355,369,386],"be":[130,443],"promising":[132],"combination.":[133],"Methods:":[134],"We":[135,162,186,200,232,249,265,275,344,364],"evaluated":[136],"molecular":[138,397],"mechanisms":[139],"underlying":[140],"cell":[142,151,157,173,202,220,262,311,316,327,333,409,497,504,511],"lethality":[143,312,498],"plus":[146,403],"melanoma,":[149,322,502],"small":[150,326,503],"lung,":[152],"ovarian,":[153,324,507],"colorectal":[155],"lines":[158,174,317,334,410,512],"mouse":[160,277,319,412,514],"xenografts.":[161],"determined":[163],"growth-adjusted":[164],"IC50s":[165],"for":[166,536],"multiple":[169],"histologies":[170,329],"choose":[172],"low":[176],"high":[178,357],"sensitivity":[179,281],"as":[184,242,446],"monotherapy.":[185],"studied":[187],"percent":[188],"growth":[189,226],"talazoparib,":[192,286],"temozolomide,":[193,285],"therapy":[196,405],"increasing":[198],"doses.":[199],"investigated":[201],"cycle":[203,221,263],"dynamics":[204],"24":[206],"hours":[207],"48":[209],"hours;":[210],"been":[214],"activate":[217],"G2/M":[219],"checkpoint,":[222],"which":[223,307],"could":[224,459],"confound":[225],"arrest":[227],"studies.":[231],"performed":[233],"western":[234,373],"blot":[235,374],"analysis":[236],"identify":[238],"phosphorylated":[239],"histone":[240],"H2AX":[241],"marker":[244],"double-strand":[247,303,471,521],"breaks.":[248],"used":[250,266,276],"FACS":[251],"determine":[253],"apoptotic":[254],"fractions":[255],"correlate":[258,270],"phospho-H2AX":[259,271,353],"formation":[260,300,518],"phase.":[264],"confocal":[267],"microscopy":[268],"nuclear":[273],"PARP.":[274],"xenografts":[278,320,413,515],"demonstrate":[280,348,370],"therapy.":[289],"Results:":[290],"The":[291,485],"results":[297,308,494],"breaks":[304,522],"during":[305,362,450,523],"S-phase,":[306],"increased":[310,496],"wild-type":[315,408,501],"colorectal,":[323],"lung":[328,505],"even":[330],"when":[331],"those":[332],"are":[335],"not":[336,367],"sensitive":[337],"either":[339],"or":[341],"alone.":[343],"were":[345,365],"unable":[346],"colocalization":[349],"due":[354,385],"PARP's":[356],"expression":[358],"nucleus":[361],"S-phase.":[363],"able":[368],"PARP-trapping":[371],"by":[372],"doses":[376],"utilized":[377],"human":[379],"patients,":[380],"but":[381],"likely":[384,429],"lack":[387],"assay":[389],"sensitivity.":[390],"Conclusions:":[391],"Taking":[392],"into":[393,468],"consideration":[394],"both":[395],"trial":[418],"showing":[420],"combination,":[426],"utility":[431],"treatment":[433],"gBRCA1/2+":[435],"patients.":[436],"Use":[437],"might":[442],"important,":[445],"it":[447],"recognized":[449],"S-phase":[451,524],"trapping":[453],"result":[460],"collapse":[462],"stalled":[465],"replication":[466],"fork":[467],"break.":[472],"Citation":[473],"Format:":[474],"Kelly":[475],"Elizabeth":[476],"McCann,":[477],"Erika":[478],"von":[479],"Euw,":[480],"Neil":[481],"O'Brien,":[482],"Dennis":[483],"Slamon.":[484],"low-dose":[492],"cancer,":[506],"colon":[509],"via":[516],"[abstract].":[525],"In:":[526],"Proceedings":[527],"Annual":[530],"Meeting":[531],"American":[534],"Association":[535],"Cancer":[537,549],"Research":[538],"2020;":[539],"2020":[540],"Apr":[541],"27-28":[542],"Jun":[544],"22-24.":[545],"Philadelphia":[546],"(PA):":[547],"AACR;":[548],"Res":[550],"2020;80(16":[551],"Suppl):Abstract":[552],"nr":[553],"4124.":[554]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2020-09-08T00:00:00"}